Sangamo Therapeutics
0.3001
+0.0400
+15.38%
SGMO
04-02 16:00:00(美东时间)
高
0.3130
开
0.2504
量
877.55万股
总市值
1.24亿
低
0.2311
换
2.12%
额
253.69万
市盈TTM
亏损
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
误人两字是功名
03-31 08:13
$Larimar(LRMR)$
$Rocket(RCKT)$
$Sangamo Therapeutics(SGMO)$
FDA发完替代路径那个法案后买入的几个罕见病都被套了
机构都看不上sgmo吗?连个私募融资都融不上
7讨论
抓住10倍股
02-27 15:11
$Sangamo Therapeutics(SGMO)$
摘要:
Sangamo Therapeutics 正处于其三十年发展历程中的关键转折点。作为锌指蛋白(ZFP)基因编辑技术的先驱,公司正经历从广泛布局的合作伙伴模式向专注神经科学的独立基因药物公司的战略转型。
其转型后的核心价值在于:差异化的神经科学研发管线、...
1赞
自由龙耀路
02-04 07:46
$Sangamo Therapeutics(SGMO)$
发了招股,以前的权证也要把价格下调,加上之前的资金是不是在埋伏这一次的数据公告?
如果真的招股,这么跌我觉得倒有些机会了,数据看上去就是g3的中风让我有一点担忧,有效性没问题,另外最担心的就是面值退市
3讨论
·
1赞
皮克斯22
02-03 22:48
$Sangamo Therapeutics(SGMO)$
洗盘吗?能顺利四月底突破并站稳一刀吗
2讨论
Sangamo Therapeutics(SGMO)
01-27 05:15
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0002041855-26-000002 Size: 6 KB
网页链接
Sangamo Therapeutics(SGMO)
01-27 05:15
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001877368-26-000002 Size: 6 KB
网页链接
蓝色枫叶xfu
03-10 19:18
$Sangamo Therapeutics(SGMO)$
这个股还有没希望,我看贝莱德一直没卖
Sangamo Therapeutics(SGMO)
01-27 05:15
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001675687-26-000002 Size: 6 KB
网页链接
Sangamo Therapeutics(SGMO)
02-03 22:05
$Sangamo Therapeutics(SGMO)$
8-K Current report, items 2.02 and 5.02 Accession Number: 0001001233-26-000002 Act: 34 Size: 146 KB
网页链接
Sangamo Therapeutics(SGMO)
02-27 10:55
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001947007-26-000004 Size: 8 KB
网页链接
Sangamo Therapeutics(SGMO)
03-31 05:45
$Sangamo Therapeutics(SGMO)$
10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-26-022029 Act: 34 Size: 34 MB
网页链接
Sangamo Therapeutics(SGMO)
02-27 10:55
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001675687-26-000004 Size: 8 KB
网页链接
Sangamo Therapeutics(SGMO)
02-27 10:55
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001877368-26-000004 Size: 8 KB
网页链接
Sangamo Therapeutics(SGMO)
02-27 10:55
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0002041855-26-000004 Size: 8 KB
网页链接
Sangamo Therapeutics(SGMO)
01-27 05:15
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001947007-26-000002 Size: 6 KB
网页链接
Sangamo Therapeutics(SGMO)
01-27 05:15
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0001779092-26-000002 Size: 6 KB
网页链接
Sangamo Therapeutics(SGMO)
01-27 05:25
$Sangamo Therapeutics(SGMO)$
4 Statement of changes in beneficial ownership of securities Accession Number: 0002089213-26-000002 Size: 6 KB
网页链接
Sangamo Therapeutics(SGMO)
02-04 21:35
$Sangamo Therapeutics(SGMO)$
424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-036786 Act: 33 Size: 660 KB
网页链接
Sangamo Therapeutics(SGMO)
02-03 22:15
$Sangamo Therapeutics(SGMO)$
FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-034556 Act: 34 Size: 155 KB
网页链接
Sangamo Therapeutics(SGMO)
02-04 21:45
$Sangamo Therapeutics(SGMO)$
8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001193125-26-036792 Act: 34 Size: 658 KB
网页链接